We encourage prospective D/P's (donor/participants) to become involved in current and future studies. If a study listed does not apply to your particular situation we still invite you to register so that we may include you in our database and contact you for future studies.
We are looking for D/P's in the following categories:
| ID # | Required D/P's | Enrolled D/P's | Remaining D/P's | Inclusion Criteria |
|---|---|---|---|---|
| 458543 | 22 | 0 | 22 | Prospective Whole Blood 120 mLs Collection in Streck Tubes from Healthy Donors >45 |
| 458534 | 84 | 0 | 84 | Prospective Whole Blood 60 mLs Collection in Streck Tubes from Healthy Donors >45 |
| 458531 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors_PR |
| 458522 | 200 | 0 | 200 | Serum Samples Collected in Lyme Non-Endemic Regions from Inventory |
| 458487 | 100 | 0 | 100 | Prospective Axilla/Groin Swab Collection Protocol from normal Population |
| 458475 | 30 | 0 | 30 | Pre-selected Chlamydia, Treponema and Gonorrhea Positive Serum Samples in Inventory |
| 458121 | 24 | 0 | 24 | Serum samples for prescreening test with backup units from Healthy Donors with BT: B or AB |
| 458089 | 6 | 0 | 6 | CT/GC Testing Service on Hologic Panther System |
| 457878 | 25 | 0 | 25 | Pre-Selected HCV Reactive Samples from Inventory / TZC0415784 |
| 457877 | 16 | 0 | 16 | Selected HIV-1 Reactive Samples from Inventory / TZC0415784 |
| 457876 | 10 | 0 | 10 | Selected HBsAg and Anti-HBc Reactive Samples from Inventory / TZC0415784 |
| 457635 | 500 | 0 | 500 | Prospective Paired Vaginal Swab (self-collected) and Cervical Swab Collection from Normal Donors |
| 457566 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors_PR |
| 457378 | 28 | 0 | 28 | Pre-selected Positive Anti-HDV Samples from Inventory |
| 457262 | 60 | 0 | 60 | Prospective Serum Samples Collection from HBV High-Risk Pediatric Donors From 18-22 Years Old |
| 457162 | 10 | 0 | 10 | Whole Blood (Venous and Capillary) from Febrile Donors |
| 457129 | 496 | 0 | 496 | Pre-Selected HBsAg Reactive Samples from Inventory |
| 457001 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors_PR |
| 456998 | 130 | 0 | 130 | Prospective Collection Paired Venous and Capillary Whole Blood from HIV-1 Positive Donors Not Taking pre-exposure prophylaxis medication for Liat Testing protocol_ SACQ_0004015/TZC0416557/SRF_0004516 |
| 456857 | 100 | 0 | 100 | Paired Nasopharyngeal and Nasal Swab Collection from SARS-CoV-2 Positive Donors Collected in UTM Media |
| 456818 | 8 | 0 | 8 | HIV-1 Positive Stability Study |
| 456596 | 2 | 0 | 2 | Pre-Selected HBV Positive Samples from Inventory |
| 456542 | 7 | 0 | 7 | Pre-Selected Chagas Positive Samples from Inventory |
| 456448 | 24 | 0 | 24 | Serum backup units from healthy donors selected after screening testing under JR453800 |
| 456435 | 8 | 0 | 8 | Prospective Serum Samples Collected from Healthy Adults with Specific Lp(a) Ranges / TZC0446562 |
| 456397 | 35 | 0 | 35 | Prospective Paired Nasal Swab Collection from Normal Healthy Donors |
| 455969 | 27 | 0 | 27 | Fresh Whole Blood Collection from Healthy Donors_PR |
| 455676 | 4 | 0 | 4 | Prospective High Volume Plasma Collection from Healthy (HxV Negative) Donors using Streck Tubes. |
| 455376 | 1020 | 0 | 1020 | cobas® TL1A Genotype Test Clinical Utility Study in Ulcerative Colitis - RD007620 Yellowstone |
| 455231 | 150 | 0 | 150 | Prospective Serum Sample Collection from Apparently Healthy Adult Subjects_TZC0438776 |
| 454434 | 22 | 0 | 22 | HIV-2 Positive Samples from Inventory With High Viral Load Collected in Florida |
| 454335 | 150 | 0 | 150 | HIV-2 Positive Pre-Test Samples from Inventory With High Viral Load with Backup Volume on Hold |
| 454280 | 50 | 0 | 50 | Prospective Nasopharyngeal Swab Collection Protocol from Symptomatic or Asymptomatic Donors |
| 454151 | 25 | 0 | 25 | Pre-Selected HIV-1 Serum Samples from Inventory with Viral Load Information |
| 453724 | 10 | 0 | 10 | Red Blood Cells and Whole Blood Samples from Healthy Donors |
| 452305 | 150 | 0 | 150 | K2EDTA Whole Blood Viral Load Screening from HIV-1 Positive Donors Collected in West Africa |
| 452303 | 2 | 0 | 2 | HCV Positive Samples with High Viral Load for Testing Purposes with Backup Volume |
| 452154 | 480 | 0 | 480 | Prospective Serum Sample Collection from Apparently Healthy Adult Subjects_TZC0416194 / ORCHID |
| 451515 | 25 | 0 | 25 | Prospective Whole Blood Collection for Healthy Donors HxV Negative_TZC0434446_ SRF_0004576 |
| 451079 | 200 | 0 | 200 | Prospective Matched Set Clinician Collected Vaginal and Cervical Swabs from Individuals with Suspected HPV / SRF_0004484 |
| 450624 | 20 | 0 | 20 | Prospective ACD fresh whole blood from healthy donors - Different donors from JR 373935 - In BD #364606 - Non Smokers - Normal Glucose Patients - lean (normal BMI_Healthy Weight) - 60 years and older |
| 449699 | 40 | 0 | 40 | Whole Blood from HIV-1 Positive Donors under Active Anti-Retroviral Therapy |
| 449322 | 2000 | 0 | 2000 | Test |
| 449200 | 810 | 0 | 810 | Evaluation of the Reproducibility of the cobas® TL1A Genotype Test on cobas® 6800/8800 Systems Across Lots _ RD007621 |
| 448183 | 100 | 0 | 100 | Paired Nasopharyngeal and Nasal Swab Collection from SARS-CoV-2 Positive Donors |
| 447230 | 15 | 0 | 15 | Pre-Selected Anti-HCV Positive Samples from Inventory for Screening Purposes. |
| 446529 | 270 | 0 | 270 | Lyme Testing Service on DSX for Negative and Positive Samples |
| 446490 | 20 | 0 | 20 | Clinical Validation Study of the Xpert® TAP Panel on the GeneXpert® Edge X System_ Protocol 273C_Pediatrics |
| 446368 | 50 | 0 | 50 | Vaginal Swabs from Chlamydia Trachomatis and/or Neisseria Gonorrhea Positive Donors |
| 445439 | 380 | 0 | 380 | Clinical Validation Study of the Xpert® TAP Panel on the GeneXpert® Edge X System_ Protocol 273C |
| 444122 | 600 | 0 | 600 | Nasopharyngeal Paired Swabs Collection from Symptomatic Donors |
| 443260 | 1200 | 0 | 1200 | Prospective Collection of Cervical Swab Specimens from Suspected Donors SRF_0004483 - Subjects must have a cervix - Subjects are suspected and/or being screened for HPV infection - Subject is 25y and older at the time of collection - HPV Vaccinated and Unvaccinated subjects acceptable. |
| 442645 | 1310 | 0 | 1310 | Prospective Wound Swab Collection from Donors Showing Signs of Infection_SRF_0004442/TZC0391787///SRF_0004515/TZC0416643 |
| 440605 | 120 | 0 | 120 | hGCH Testing Service on DiaSorin LIAISON and Beckman Access Assays. |
| 433878 | 110 | 0 | 110 | Evaluation of Selected BD Vacutainer® Blood Collection Tubes in Blood Donor Screening for Infectious Disease Testing_PAS-18SUST025_Part B-Anti-HCV |
| 433876 | 110 | 0 | 110 | Evaluation of Selected BD Vacutainer® Blood Collection Tubes in Blood Donor Screening for Infectious Disease Testing_PAS-18SUST025_Part A-Syphilis |
| 433653 | 50 | 0 | 50 | Prospective Whole Blood Collection from Healthy Donors_Puerto Rico |
| 427881 | 20 | 0 | 20 | Prospective First-Morning Urine Void from Pediatric Donors |
| 427570 | 10000 | 0 | 10000 | Pre-selected Samples for Abbott (Generic JR) |
| 426715 | 500 | 0 | 500 | Prospective Vaginal Swab Collection (Self-Collected and Clinician Collected) from Symptomatic Vaginitis Donors and Testing_ RD007312 liat TV/CV |
| 425566 | 10000 | 0 | 10000 | A Multi-Site, Point in Time, Collection Protocol in order to obtain Blood (finger stick or venous), urine, stool and/or swabs Samples from Healthy Pediatric D/Ps (Donor/Participants). |
| 424413 | 30 | 0 | 30 | PAS-19SUST054 - Evaluation of the Clinical Performance of BD Vacutainer® PPT™ Plasma Preparation Tube with Hemogard™ Closure using Molecular Diagnostic Testing for Hepatitis C Virus (HCV) Viral Load (VL) Assay. |
| 415606 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Oral, Rectal, Urethral, Urine, Hair, Lesion, Saliva, Sputum, Sperm and/or Stool Specimens. - Genetic Testing |
| 413245 | 80 | 0 | 80 | Whole Blood Collection from HIV Donors with acceptable CD4 levels for Protocol CAS24TBNKSTB |
| 413243 | 150 | 0 | 150 | Whole Blood Collection from HIV Donors for CD4 Screening Testing Purposes_Protocol CAS24TBNKSTB |
| 411746 | 200 | 0 | 200 | Prospective Sample Collection for Pregnant Subjects at Risk for Bloodborne Viral Hepatitis_TZC0275622 |
| 407536 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Oral, Rectal, Urethral, Urine, Hair, Lesion, Saliva, Sputum, Sperm and/or Stool Specimens. - Genetic Testing |
| 401668 | 10000 | 0 | 10000 | A Multi-Site, Point in Time, Prospective Collection Protocol in order to obtain Blood Samples from Healthy Pediatric D/Ps (Donor/Participants). |
| 400054 | 200 | 0 | 200 | Prospective Serum Samples Collection from HBV High-Risk Donors |
| 399298 | 10000 | 0 | 10000 | HxV and/or CBC Initiative |
| 392210 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 392167 | 35000 | 0 | 35000 | Customer Samples kept in Biorepository (Markland Hamilton) |
| 389554 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 389553 | 10000 | 0 | 10000 | A Multi-Site, Point in Time, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, and/or Blood Samples from Pediatric D/Ps (Donor/Participants). |
| 382256 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 377709 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Blood, finger stick, Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens. |
| 373958 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Endocervical, Vaginal, Nasal, Pharyngeal, Rectal, Urethral and/or Urine Specimens |
| 373511 | 100 | 0 | 100 | HBsAg, HIV-Ag, and HCV-Ag cassette evaluation using fresh whole blood samples and fresh whole blood spiked samples. |
| 373102 | 10000 | 0 | 10000 | A Multi-Site, Point in Time, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, and/or Blood Samples from Pediatric D/Ps (Donor/Participants). |
| 366644 | 5000 | 9 | 4991 | Refer to Processing Instructions @ Attachment Tab |
| 329522 | 4338 | 8647 | -4309 | Disposition of BioRepository Samples -Urine and Plasma Negative samples from Talents |
| 292590 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, Vaginal Swab, Rectal Swab, Lesion Swab, Saliva Sample and/or Blood Samples from a positive or suspected positive D/Ps with Monkeypox |
| 283190 | 200 | 113 | 87 | Protocol No. LIA-STI-250 - cobas CT/NG/MG Nucleic acid test for use on the cobas Liat System: Feasibility Performance Evaluation |
| 282610 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Sample Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 251350 | 100 | 44 | 56 | SARS-CoV-2 Positive Nasal, Oropharyngeal Dry Swab and Raw Saliva Collection Protocol |
| 242206 | 50000 | 27712 | 22288 | COVID-19 Testing |
| 225611 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Saliva, Sputum, Nasal, Pharyngeal, Blood and/or Finger Stick from Donor/Participants (D/Ps) in different Regions of the World. |
| 190737 | 5000 | 95 | 4905 | SARS-CoV-2 Survey (PT) |
| 173768 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Saliva, Sputum, Nasal, Pharyngeal, Blood and/or Finger Stick Specimens from SARS-CoV-2 positive subjects |
| 152854 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 151681 | 5000 | 3 | 4997 | Refer to Processing Instructions @ Attachment Tab |
| 149547 | 5000 | 390 | 4610 | Refer to Processing Instructions @ Attachment Tab TESTS TO SELECT PER LOCATION - REFER TO ATTACHMENT TAB |
| 148791 | 5000 | 56 | 4944 | Refer to Processing Instructions @ Attachment Tab |
| 145574 | 5000 | 165 | 4835 | Refer to Processing Instructions @ Attachment Tab |
| 144620 | 5000 | 79 | 4921 | Refer to Processing Instructions @ Attachment Tab |
| 142755 | 5000 | 167 | 4833 | Refer to Processing Instructions @ Attachment Tab |
| 141914 | 1000 | 7 | 993 | HIV Initiative |
| 141493 | 5000 | 75 | 4925 | HCV Viral Load and Genotype Survey (PT) |
| 141491 | 5000 | 30 | 4970 | HBV Viral Load Survey (PT) |
| 141490 | 5000 | 90 | 4910 | HIV Viral Load Survey (PT) |
| 140923 | 5000 | 161 | 4839 | Refer to Processing Instructions @ Attachment Tab |
| 140922 | 5000 | 75 | 4925 | Refer to Processing Instructions @ Attachment Tab |
| 140530 | 5000 | 10 | 4990 | Rubella IgG (AAB - PT) |
| 140528 | 5000 | 6 | 4994 | ToRCH (AAB - PT) |
| 139409 | 5000 | 171 | 4829 | Pregnancy (PT) |
| 137933 | 5000 | 0 | 5000 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon |
| 129538 | 1000 | 309 | 691 | RPR Initiative |
| 122931 | 5000 | 4092 | 908 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella |
| 120851 | 140 | 26 | 114 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV |
| 108692 | 2000 | 1268 | 732 | HxV Testing Initiative |
| 102419 | 1000 | 681 | 319 | Samples on hold for future shipments to China |
| 98830 | 10000 | 0 | 10000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP, Endocervical Swab, Vaginal Swab, Nasal Swab, Pharyngeal Swab, Rectal Swab, Urethral Swab and/or Urine Samples |
| 98084 | 1000 | 576 | 424 | CBC Qualifying Job Request |
| 96055 | 40 | 2275 | -2235 | Hologic Panels for HIV and HCV |
| 94841 | 500 | 1 | 499 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV - LGR |
| 78138 | 300 | 140 | 160 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV |
| 78137 | 300 | 414 | -114 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV |
| 74261 | 10000 | 0 | 10000 | A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella |
| 68258 | 10000 | 0 | 10000 | A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps |
| 63868 | 1000 | 1585 | -585 | Blinded HIV/HBV/HCV Prospective Blood Collection Protocol from Guinea Bissau |
| 56717 | 20000 | 0 | 20000 | A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP , Endocervical, Vaginal, Nasal and/or Urine Samples |
| 27615 | 15000 | 633 | 14367 | Prospective Blood Collection Protocol in order to Collect Samples from Donor/Participants (D/Ps) in Low Socio-Economic Regions of the World |
| 26761 | 10000 | 482 | 9518 | HIV Positive Time Stability Whole Blood Collection Protocol |
| 10694 | 3000 | 2234 | 766 | HCV Longitudinal Prospective Blood Collection Protocol |
| 10693 | 3000 | 369 | 2631 | HBV Multi-Point Prospective Blood Collection Protocol |
| 8568 | 300 | 1777 | -1477 | Positive Plasma Units from Blood Centers Around the World (HIV, HBsAg & HCV) |
BCW helps clinicians during their research process through collection sites and D/P availability. Our collection sites have been duly inspected and adhere to our Good Manufacturing Practices thus ensuring reliability during the collection process. In addition to this we provide training seminars as part of our Quality Assurance in order to maintain the level of quality that our customers are accustomed to.
You will be invited to participate in research studies for the advancement of diagnostic technologies. Participation in these studies is voluntary. Our D/P's are informed of what the research projects are about and are given an Informed Consent, which evidences their willingness to participate. In order to protect our D/P's we never divulge your identity to the research facilities thus guaranteeing D/P confidentiality.
